|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2023―Dec―10 |
COVID-19 severity and risk factors in Iranian patients with rheumatic diseases |
|
2 |
[GO] |
2023―Dec―05 |
COVID-19 reinfection in rheumaic patients: Clinical characteristics and risk factors |
|
3 |
[GO] |
2023―Dec―04 |
Assessment of self-medication in patients with rheumatoid arthritis referred to Rafsanjan Rheumatology Clinic during the COVID-19 pandemic |
|
4 |
[GO] |
2023―Dec―04 |
Immune-mediated necrotizing myositis following SARS-Cov-2: A case report |
|
5 |
[GO] |
2022―May―07 |
The prevalence of Covid-19 in patients with Rheumatoid Arthritis receiving classic Disease-Modifying Anti Rheumatic Drugs |
Arman Ahmadzadeh, sareh basiri, Faraneh Farsad, Mohammadmahdi emam, Alireza Rajaei |
6 |
[GO] |
2022―May―07 |
Clinical characteristics associated with hospitalization and mortality of coronavirus disease-2019 (COVID-19) infection in rheumatic patients: a cross-sectional study from Iran |
Shirin Assar, Dena Mohamadzadeh, Mehran Pournazari, Parviz Soufivand |
7 |
[GO] |
2022―May―07 |
Musculoskeletal Manifestations of COVID-19: A Systematic Search and Review |
Moshiur Khasru, Md Abu Siddiq, Tangila Marzen, Md Rahman, Iffat Islam, Syed Refaie, et al. (+8) Md Ali, ATM Uddin, Mohammad Hasan, Radia Naz, Fariha Haseen, Syed Islam, Daniel Clegg, Johannes J Rasker |
8 |
[GO] |
2022―May―07 |
Glucocorticoids could be safe in COVID-19; a case series |
Sina Owlia, Zohreh Akhondi-Meybodi, Golbarg Mehrpoor, Mehrdad Aghaei, Zahra Mirfeizi, Mohammad Bagher Owlia, Seyed Ruhollah Mousavinasab |
9 |
[GO] |
2021―Jun―19 |
Resolved of Respiratory Failure Following the Use Pulse-Doses of Methylprednisolone in a Cytokine Storm Related to 2019 novel coronavirus |
Hamid Khederlou, Abdolrahman Rostamian, Elham Nezhadseifi, Hourvash Ebrahimi-louyeh |